Lars Fruergaard Jorgensen
Verkställande Direktör på NOVO NORDISK A/S
Profil
Lars Fruergaard Jørgensen currently works at Novo Nordisk A, as President & Chief Executive Officer from 2017, Novo Nordisk Ltd., as President & Chief Executive Officer from 2004, Harno Invest A, as Chairman, European Federation of Pharmaceutical Industries & Assns, as Vice President from 2021, and Federation Européenne D'Associations Et D'Industries Pharma, as President.
Mr. Jørgensen also formerly worked at Carlsberg A, as Vice Chairman-Supervisory Board, Carlsberg Breweries A, as Vice Chairman-Supervisory Board, NNE Pharmaplan A, as Vice Chairman, ZymoGenetics, Inc., as Director in 2010, NNIT A, as Director from 2005 to 2015, Innate Pharma SA, as Member-Supervisory Board from 2007 to 2013, and Novo Nordisk SAS, as Vice President-Finance & Information Technology in 2004.
Mr. Jørgensen received his graduate degree in 1991 from the University of Aarhus.
Senaste nyheterna om Lars Fruergaard Jorgensen
Aktiva positioner av Lars Fruergaard Jorgensen
| Företag | Position | Start |
|---|---|---|
| NOVO NORDISK A/S | Verkställande Direktör | 01.01.2017 |
Novo Nordisk Ltd.
 Novo Nordisk Ltd. Medical/Nursing ServicesHealth Services Novo Nordisk Ltd. engages in the sale and marketing of pharmaceutical products for the treatment of chronic conditions in the United Kingdom. It offers medicines for the treatment of diabetes, and hemophilia and bleeding disorders, as well as for growth hormone therapy and hormone replacement therapy. The company is headquartered in Crawley, the United Kingdom. | Verkställande Direktör | 01.09.2004 |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Företagsledare/Principal | 01.01.2021 |
Tidigare kända positioner av Lars Fruergaard Jorgensen
| Företag | Position | Slut |
|---|---|---|
| NNIT A/S | Direktör/Styrelseledamot | 06.03.2015 |
| INNATE PHARMA | Direktör/Styrelseledamot | 04.03.2013 |
Harno Invest A/S
 Harno Invest A/S Financial ConglomeratesFinance Harno Invest A/S provides investment and financial services. The company was founded in 2002 and is located in Copenhagen, Denmark | Ordförande | - |
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Direktör/Styrelseledamot | 08.10.2010 |
Novo Nordisk SAS
 Novo Nordisk SAS Pharmaceuticals: MajorHealth Technology Novo Nordisk SAS manufactures pharmaceutical drugs. It produces and sells medicines for the treatment of diabetes, haemophilia, and hormonal disease. The company was founded in 1959 and is headquartered in Paris, France. | Finansdirektör/CFO | 01.01.2004 |
Utbildning av Lars Fruergaard Jorgensen
| University of Aarhus | Graduate Degree |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Börsnoterade företag | 4 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| NNIT A/S | Technology Services |
| INNATE PHARMA | Health Technology |
| CARLSBERG A/S | Consumer Non-Durables |
| Privata företag | 7 |
|---|---|
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |
Harno Invest A/S
Harno Invest A/S Financial ConglomeratesFinance Harno Invest A/S provides investment and financial services. The company was founded in 2002 and is located in Copenhagen, Denmark | Finance |
Novo Nordisk SAS
Novo Nordisk SAS Pharmaceuticals: MajorHealth Technology Novo Nordisk SAS manufactures pharmaceutical drugs. It produces and sells medicines for the treatment of diabetes, haemophilia, and hormonal disease. The company was founded in 1959 and is headquartered in Paris, France. | Health Technology |
NNE Pharmaplan A/S
 NNE Pharmaplan A/S Pharmaceuticals: MajorHealth Technology NNE Pharmaplan A/S produces pharmaceutical products. The company is based in Soborg, Denmark. | Health Technology |
Novo Nordisk Ltd.
Novo Nordisk Ltd. Medical/Nursing ServicesHealth Services Novo Nordisk Ltd. engages in the sale and marketing of pharmaceutical products for the treatment of chronic conditions in the United Kingdom. It offers medicines for the treatment of diabetes, and hemophilia and bleeding disorders, as well as for growth hormone therapy and hormone replacement therapy. The company is headquartered in Crawley, the United Kingdom. | Health Services |
Carlsberg Breweries A/S
 Carlsberg Breweries A/S Beverages: AlcoholicConsumer Non-Durables Carlsberg Breweries A/S engages in the production and marketing of beer and soft drinks. The firm's brands include Afsana, Backyard Brew, CELIA, Dahls, and Eriksberg. It operates through the following geographical segments: Western Europe; Asia; Eastern Europe; and Central and Eastern Europe. The company was founded by Jacob Christian Jacobsen in 1847 and is headquartered in Copenhagen, Denmark. | Consumer Non-Durables |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Commercial Services |
